TreeWAS – Variant ID: rs1873747

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K22.8 Other specified diseases of oesophagus	0.000	0.980	0.020
N42.8 Other specified disorders of prostate	0.013	0.987	0.000
N42 Other disorders of prostate	0.012	0.988	0.000
N42.9 Disorder of prostate, unspecified	0.012	0.988	0.000
N39.4 Other specified urinary incontinence	0.000	0.989	0.011
N42.0 Calculus of prostate	0.011	0.989	0.000
N42.1 Congestion and haemorrhage of prostate	0.011	0.989	0.000
T51.0 Ethanol	0.000	0.990	0.010
J36 Peritonsillar abscess	0.000	0.990	0.010
N42.2 Atrophy of prostate	0.010	0.990	0.000
N42.3 Dysplasia of prostate	0.009	0.991	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.008	0.992	0.000
F41.2 Mixed anxiety and depressive disorder	0.008	0.992	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.992	0.008
F41.1 Generalised anxiety disorder	0.008	0.992	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.993	0.007
F40.2 Specific (isolated) phobias	0.007	0.993	0.000
T51 Toxic effect of alcohol	0.000	0.993	0.007
F41 Other anxiety disorders	0.006	0.994	0.000
T42.4 Benzodiazepines	0.000	0.994	0.006
T90.4 Sequelae of injury of eye and orbit	0.006	0.994	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.994	0.006
F40 Phobic anxiety disorders	0.006	0.994	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.994	0.006
T90 Sequelae of injuries of head	0.006	0.994	0.000
T51.9 Alcohol, unspecified	0.000	0.995	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.995	0.005
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.995	0.005
T42.3 Barbiturates	0.000	0.995	0.005
T42.2 Succinimides and oxazolidinediones	0.000	0.995	0.005
T42.0 Hydantoin derivatives	0.000	0.995	0.005
T82.1 Mechanical complication of cardiac electronic device	0.005	0.995	0.000
T90.9 Sequelae of unspecified injury of head	0.005	0.995	0.000
T51.8 Other alcohols	0.000	0.995	0.005
T51.3 Fusel oil	0.000	0.995	0.005
T51.2 2-Propanol	0.000	0.995	0.005
T51.1 Methanol	0.000	0.995	0.005
C44.2 Skin of ear and external auricular canal	0.000	0.995	0.005
T90.2 Sequelae of fracture of skull and facial bones	0.005	0.995	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.005	0.995	0.000
F41.3 Other mixed anxiety disorders	0.005	0.995	0.000
T42.1 Iminostilbenes	0.000	0.995	0.005
T90.5 Sequelae of intracranial injury	0.005	0.995	0.000
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.005	0.995	0.000
F41.8 Other specified anxiety disorders	0.005	0.995	0.000
T84.1 Mechanical complication of internal fixation device of bones of limb	0.000	0.995	0.005
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.000	0.995	0.005
F40.9 Phobic anxiety disorder, unspecified	0.005	0.995	0.000
T90.0 Sequelae of superficial injury of head	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.995	0.005
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts	0.000	0.995	0.005
H91.9 Hearing loss, unspecified	0.004	0.996	0.000
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts	0.000	0.996	0.004
T45.5 Anticoagulants	0.000	0.996	0.004
F40.8 Other phobic anxiety disorders	0.004	0.996	0.000
F40.1 Social phobias	0.004	0.996	0.000
T84.0 Mechanical complication of internal joint prosthesis	0.000	0.996	0.004
F44 Dissociative [conversion] disorders	0.004	0.996	0.000
T90.1 Sequelae of open wound of head	0.004	0.996	0.000
T84.3 Mechanical complication of other bone devices, implants and grafts	0.000	0.996	0.004
T90.3 Sequelae of injury of cranial nerves	0.004	0.996	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
Z42.1 Follow-up care involving plastic surgery of breast	0.004	0.996	0.000
T90.8 Sequelae of other specified injuries of head	0.004	0.996	0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.004	0.996	0.000
F48 Other neurotic disorders	0.004	0.996	0.000
T58 Toxic effect of carbon monoxide	0.000	0.996	0.004
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.004	0.996	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.004	0.996	0.000
F45 Somatoform disorders	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
W55.0 Home	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.004
T59 Toxic effect of other gases, fumes and vapours	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
F44.9 Dissociative [conversion] disorder, unspecified	0.004	0.996	0.000
F40.0 Agoraphobia	0.003	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.003
T45.4 Iron and its compounds	0.000	0.996	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.003
T84.2 Mechanical complication of internal fixation device of other bones	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.003
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.004	0.996	0.000
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.000	0.996	0.004
F42 Obsessive-compulsive disorder	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.996	0.004
F44.5 Dissociative convulsions	0.003	0.996	0.000
T59.8 Other specified gases, fumes and vapours	0.000	0.996	0.003
T39.0 Salicylates	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
F44.4 Dissociative motor disorders	0.003	0.997	0.000
H91 Other hearing loss	0.003	0.997	0.000
F44.8 Other dissociative [conversion] disorders	0.003	0.997	0.000
F44.7 Mixed dissociative [conversion] disorders	0.003	0.997	0.000
F44.6 Dissociative anaesthesia and sensory loss	0.003	0.997	0.000
F44.3 Trance and possession disorders	0.003	0.997	0.000
F44.2 Dissociative stupor	0.003	0.997	0.000
F44.1 Dissociative fugue	0.003	0.997	0.000
F44.0 Dissociative amnesia	0.003	0.997	0.000
G12.2 Motor neuron disease	0.003	0.997	0.000
F45.3 Somatoform autonomic dysfunction	0.003	0.997	0.000
F48.9 Neurotic disorder, unspecified	0.003	0.997	0.000
T56 Toxic effect of metals	0.000	0.997	0.003
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft	0.000	0.997	0.003
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.000	0.997	0.003
T62 Toxic effect of other noxious substances eaten as food	0.000	0.997	0.003
T61 Toxic effect of noxious substances eaten as seafood	0.000	0.997	0.003
T60 Toxic effect of pesticides	0.000	0.997	0.003
T57 Toxic effect of other inorganic substances	0.000	0.997	0.003
T54 Toxic effect of corrosive substances	0.000	0.997	0.003
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.000	0.997	0.003
T52 Toxic effect of organic solvents	0.000	0.997	0.003
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.000	0.997	0.003
T55 Toxic effect of soaps and detergents	0.000	0.997	0.003
W55 Bitten or struck by other mammals	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
F48.8 Other specified neurotic disorders	0.003	0.997	0.000
F48.1 Depersonalisation-derealisation syndrome	0.003	0.997	0.000
R74.8 Abnormal levels of other serum enzymes	0.000	0.997	0.003
T82.0 Mechanical complication of heart valve prosthesis	0.003	0.997	0.000
T91.1 Sequelae of fracture of spine	0.003	0.997	0.000
F48.0 Neurasthenia	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
M25.86 Other specified joint disorders (Lower leg)	0.000	0.997	0.003
F45.9 Somatoform disorder, unspecified	0.003	0.997	0.000
F45.4 Persistent somatoform pain disorder	0.003	0.997	0.000
F45.2 Hypochondriacal disorder	0.003	0.997	0.000
F45.1 Undifferentiated somatoform disorder	0.003	0.997	0.000
F45.0 Somatisation disorder	0.003	0.997	0.000
I84.7 Unspecified thrombosed haemorrhoids	0.003	0.997	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
T59.9 Gases, fumes and vapours, unspecified	0.000	0.997	0.003
T59.7 Carbon dioxide	0.000	0.997	0.003
T59.6 Hydrogen sulphide	0.000	0.997	0.003
T59.5 Fluorine gas and hydrogen fluoride	0.000	0.997	0.003
T59.4 Chlorine gas	0.000	0.997	0.003
T59.3 Lachrymogenic gas	0.000	0.997	0.003
T59.2 Formaldehyde	0.000	0.997	0.003
T59.1 Sulphur dioxide	0.000	0.997	0.003
T59.0 Nitrogen oxides	0.000	0.997	0.003
T65 Toxic effect of other and unspecified substances	0.000	0.997	0.003
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.003	0.997	0.000
F42.8 Other obsessive-compulsive disorders	0.003	0.997	0.000
F42.2 Mixed obsessional thoughts and acts	0.003	0.997	0.000
F42.1 Predominantly compulsive acts [obsessional rituals]	0.003	0.997	0.000
F42.0 Predominantly obsessional thoughts or ruminations	0.003	0.997	0.000
H91.8 Other specified hearing loss	0.003	0.997	0.000
H93.9 Disorder of ear, unspecified	0.003	0.997	0.000
K31.7 Polyp of stomach and duodenum	0.000	0.997	0.003
R59.0 Localised enlarged lymph nodes	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
T82.4 Mechanical complication of vascular dialysis catheter	0.003	0.997	0.000
H93 Other disorders of ear, not elsewhere classified	0.003	0.997	0.000
W50-W64 Exposure to animate mechanical forces	0.003	0.997	0.000
T56.8 Other metals	0.000	0.997	0.003
F45.8 Other somatoform disorders	0.003	0.997	0.000
H95.1 Other disorders following mastoidectomy	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
H57.0 Anomalies of pupillary function	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.002
H91.3 Deaf mutism, not elsewhere classified	0.003	0.997	0.000
H91.2 Sudden idiopathic hearing loss	0.003	0.997	0.000
H91.1 Presbycusis	0.003	0.997	0.000
H91.0 Ototoxic hearing loss	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.000	0.997	0.003
M47.9 Spondylosis, unspecified	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.002
H93.1 Tinnitus	0.003	0.997	0.000
T56.9 Metal, unspecified	0.000	0.997	0.002
T56.7 Beryllium and its compounds	0.000	0.997	0.002
T56.6 Tin and its compounds	0.000	0.997	0.002
T56.5 Zinc and its compounds	0.000	0.997	0.002
T56.4 Copper and its compounds	0.000	0.997	0.002
T56.3 Cadmium and its compounds	0.000	0.997	0.002
T56.2 Chromium and its compounds	0.000	0.997	0.002
T56.1 Mercury and its compounds	0.000	0.997	0.002
T56.0 Lead and its compounds	0.000	0.997	0.002
T63 Toxic effect of contact with venomous animals	0.000	0.997	0.002
Y41.5 Antiviral drugs	0.003	0.997	0.000
A87.9 Viral meningitis, unspecified	0.000	0.997	0.003
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.003	0.997	0.000
C44.6 Skin of upper limb, including shoulder	0.000	0.997	0.003
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.002
T43.2 Other and unspecified antidepressants	0.000	0.997	0.003
Y40.0 Penicillins	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.002
T52.9 Organic solvent, unspecified	0.000	0.997	0.002
T52.8 Other organic solvents	0.000	0.997	0.002
T52.4 Ketones	0.000	0.997	0.002
T52.3 Glycols	0.000	0.997	0.002
T52.2 Homologues of benzene	0.000	0.997	0.002
T52.1 Benzene	0.000	0.997	0.002
T52.0 Petroleum products	0.000	0.997	0.002
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.000	0.997	0.002
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.000	0.997	0.002
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.000	0.997	0.002
T53.5 Chlorofluorocarbons	0.000	0.997	0.002
T53.4 Dichloromethane	0.000	0.997	0.002
T53.3 Tetrachloroethylene	0.000	0.997	0.002
T53.2 Trichloroethylene	0.000	0.997	0.002
T53.1 Chloroform	0.000	0.997	0.002
T53.0 Carbon tetrachloride	0.000	0.997	0.002
T54.9 Corrosive substance, unspecified	0.000	0.997	0.002
T54.3 Corrosive alkalis and alklali-like substances	0.000	0.997	0.002
T54.2 Corrosive acids and acid-like substances	0.000	0.997	0.002
T54.1 Other corrosive organic compounds	0.000	0.997	0.002
T54.0 Phenol and phenol homologues	0.000	0.997	0.002
T57.9 Inorganic substance, unspecified	0.000	0.997	0.002
T57.8 Other specified inorganic substances	0.000	0.997	0.002
T57.3 Hydrogen cyanide	0.000	0.997	0.002
T57.2 Manganese and its compounds	0.000	0.997	0.002
T57.1 Phosphorus and its compounds	0.000	0.997	0.002
T57.0 Arsenic and its compounds	0.000	0.997	0.002
T60.9 Pesticide, unspecified	0.000	0.997	0.002
T60.8 Other pesticides	0.000	0.997	0.002
T60.4 Rodenticides	0.000	0.997	0.002
T60.3 Herbicides and fungicides	0.000	0.997	0.002
T60.2 Other insecticides	0.000	0.997	0.002
T60.1 Halogenated insecticides	0.000	0.997	0.002
T60.0 Organophosphate and carbamate insecticides	0.000	0.997	0.002
T61.9 Toxic effect of unspecified seafood	0.000	0.997	0.002
T61.8 Toxic effect of other seafoods	0.000	0.997	0.002
T61.2 Other fish and shellfish poisoning	0.000	0.997	0.002
T61.1 Scombroid fish poisoning	0.000	0.997	0.002
T61.0 Ciguatera fish poisoning	0.000	0.997	0.002
T62.9 Noxious substance eaten as food, unspecified	0.000	0.997	0.002
T62.8 Other specified noxious substances eaten as food	0.000	0.997	0.002
T62.2 Other ingested (parts of) plant(s)	0.000	0.997	0.002
T62.1 Ingested berries	0.000	0.997	0.002
T62.0 Ingested mushrooms	0.000	0.997	0.002
W50.2 School, other institution and public administrative area	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
W55.9 Unspecified place	0.002	0.997	0.000
W55.5 Trade and service area	0.002	0.997	0.000
W55.7 Farm	0.002	0.997	0.000
W55.6 Industrial and construction area	0.002	0.997	0.000
W55.4 Street and highway	0.002	0.997	0.000
W55.3 Sports and athletics area	0.002	0.997	0.000
W55.2 School, other institution and public administrative area	0.002	0.997	0.000
W55.1 Residential institution	0.002	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.002
F42.9 Obsessive-compulsive disorder, unspecified	0.002	0.997	0.000
G95.2 Cord compression, unspecified	0.000	0.997	0.003
W55.8 Other specified place	0.002	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.002
Y43 Primarily systemic agents	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.002
Y41.0 Sulphonamides	0.002	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.002
T36.8 Other systemic antibiotics	0.000	0.997	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
T36.6 Rifamycins	0.000	0.997	0.002
T36.5 Aminoglycosides	0.000	0.997	0.002
T36.4 Tetracyclines	0.000	0.997	0.002
T36.3 Macrolides	0.000	0.997	0.002
T36.2 Chloramphenicol group	0.000	0.997	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.997	0.000
C44.7 Skin of lower limb, including hip	0.000	0.998	0.002
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
W60 Contact with plant thorns and spines and sharp leaves	0.002	0.998	0.000
H90-H95 Other disorders of ear	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
T65.8 Toxic effect of other specified substances	0.000	0.998	0.002
T65.6 Paints and dyes, not elsewhere classified	0.000	0.998	0.002
T65.5 Nitroglycerin and other nitric acids and esters	0.000	0.998	0.002
T65.4 Carbon disulphide	0.000	0.998	0.002
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.000	0.998	0.002
T65.2 Tobacco and nicotine	0.000	0.998	0.002
T65.1 Strychnine and its salts	0.000	0.998	0.002
T65.0 Cyanides	0.000	0.998	0.002
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.002	0.998	0.000
W03.9 Unspecified place	0.002	0.998	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.002	0.998	0.000
H93.3 Disorders of acoustic nerve	0.002	0.998	0.000
H93.2 Other abnormal auditory perceptions	0.002	0.998	0.000
H93.0 Degenerative and vascular disorders of ear	0.002	0.998	0.000
H93.8 Other specified disorders of ear	0.002	0.998	0.000
J03.9 Acute tonsillitis, unspecified	0.002	0.998	0.000
U89.8 Agent resistant to other single specified antibiotic	0.002	0.998	0.000
W64 Exposure to other and unspecified animate mechanical forces	0.002	0.998	0.000
W59 Bitten or crushed by other reptiles	0.002	0.998	0.000
W58 Bitten or struck by crocodile or alligator	0.002	0.998	0.000
W56 Contact with marine animal	0.002	0.998	0.000
W54 Bitten or struck by dog	0.002	0.998	0.000
W53 Bitten by rat	0.002	0.998	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.002	0.998	0.000
W51 Striking against or bumped into by another person	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.998	0.002
T63.8 Toxic effect of contact with other venomous animals	0.000	0.998	0.002
T63.6 Toxic effect of contact with other marine animals	0.000	0.998	0.002
T63.5 Toxic effect of contact with fish	0.000	0.998	0.002
T63.3 Venom of spider	0.000	0.998	0.002
T63.2 Venom of scorpion	0.000	0.998	0.002
T63.1 Venom of other reptiles	0.000	0.998	0.002
T63.0 Snake venom	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.002	0.998	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.002	0.998	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.998	0.002
W50.3 Sports and athletics area	0.002	0.998	0.000
W50.8 Other specified place	0.002	0.998	0.000
W50.7 Farm	0.002	0.998	0.000
W50.6 Industrial and construction area	0.002	0.998	0.000
W50.5 Trade and service area	0.002	0.998	0.000
W50.4 Street and highway	0.002	0.998	0.000
W50.1 Residential institution	0.002	0.998	0.000
W50.0 Home	0.002	0.998	0.000
W57.0 Home	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.002	0.998	0.000
G95.8 Other specified diseases of spinal cord	0.000	0.998	0.002
W60.0 Home	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
W55.58 Bitten or struck by other mammals; Trade and service area;While engaged in other specified activities	0.002	0.998	0.000
W55.99 Bitten or struck by other mammals: Unspecified place: During unspecified activity	0.002	0.998	0.000
T82.3 Mechanical complication of other vascular grafts	0.002	0.998	0.000
W60.9 Unspecified place	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
C44 Other malignant neoplasms of skin	0.000	0.998	0.002
W03 Other fall on same level due to collision with, or pushing by, another person	0.002	0.998	0.000
B01.9 Varicella without complications	0.002	0.998	0.000
T65.9 Toxic effect of unspecified substance	0.000	0.998	0.002
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
W50.9 Unspecified place	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.002	0.998	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.000	0.998	0.002
T84.4 Mechanical complication of other internal orthopaedic devices, imnplants and grafts	0.000	0.998	0.002
Y40.5 Aminoglycosides	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
X10-X19 Contact with heat and hot substances	0.002	0.998	0.000
W60.8 Other specified place	0.002	0.998	0.000
W60.7 Farm	0.002	0.998	0.000
W60.6 Industrial and construction area	0.002	0.998	0.000
W60.5 Trade and service area	0.002	0.998	0.000
W60.4 Street and highway	0.002	0.998	0.000
W60.3 Sports and athletics area	0.002	0.998	0.000
W60.2 School, other institution and public administrative area	0.002	0.998	0.000
W60.1 Residential institution	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.000	0.998	0.002
W57.9 Unspecified place	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations